All updated as on -
The Intravenous solution market Size was valued at USD 6.8 billion in 2022 and is projected to grow from USD 7 Billion in 2023 to USD 11.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8% during the forecast period (2023 - 2030). The key factors driving the expansion of the intravenous solution market include rising chronic disease incidence and prevalence, an aging global population, and rapidly increasing healthcare spending on IV therapy treatment.
Key factors driving the market growth include increasing pet ownership, the prevalence of diseases such as anthrax, pancreatitis, and oral disease, and rising awareness about animal welfare. There has been a noticeable increase in the prevalence of various animal diseases and conditions, leading to a higher demand for veterinary IV fluid therapy. Conditions such as disease, dehydration, infections, and surgical procedures often require intravenous fluid administration to support the animal's health and recovery.
New intravenous injection solutions are being introduced by market participants, which is anticipated to accelerate the growth of the global intravenous solutions market in the upcoming years. For example, Baxter International Inc., a global sterile medication production company, announced the FDA approval and commercial launch of premix Bitartrate in 5% Dextrose Injection in September 2021. In adults with severe, acute hypotension, is prescribed to raise blood pressure (low blood pressure). Baxter's formulation is the first and only producer of ready-to-use formulation available in four strengths: 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL).
Parenteral (intravenous) nutrition (PN) product launches by key market players for developing global intravenous solutions are anticipated to propel market growth in the forecast period. For instance, in June 2019, the Indian pharmaceutical market saw the introduction of the intravenous IV products Lifeport and Discport by Eurolife Healthcare, a manufacturer and distributor of specialty infusion & pharmaceuticals. The product, which uses advanced technology to lower the risk of infection, is regarded as a smart intravenous infusion. The fluid treatment is one of the most popular therapies in small animal medicine. In veterinary medicine, intravenous fluid treatment is frequently used to treat dehydration, restore intravascular volume, and provide intravenous (IV) drugs. The ability to put IV catheters is a fundamental nursing skill for veterinary technologists and enables IV fluid therapy for hospitalized patients and emergency presentations. Access to the vascular area also enables other treatments, such as parenteral nutrition, transfusions, and medicines.
The need for nutrition-rich food and a focus on food safety has become increasingly important in the veterinary IV solutions market. Nutrition plays a vital role in supporting the health and recovery of animals, especially those receiving intravenous fluid therapy. IV fluids can be supplemented with essential nutrients, such as vitamins, minerals, and amino acids, to provide complete and balanced nutrition. The demand for nutrition-rich IV fluids has increased as veterinarians recognize the importance of meeting the nutritional needs of animals during illness, surgery, or critical care.
North America, with the bulk of the overall market share, is the dominant market for intravenous solutions. The regional market is being driven by the rapid development of the United States manufacturing capacity owing to a shortage of IV fluids. Moreover, developing countries, including India and China, are increasing their investments in the health sector, which is likely to boost the demand for intravenous solutions. Additionally, manufacturers are implementing new product technologies like offering premixed options for greater convenience and reducing packaging waste.
The development of IV fluids has seen tremendous growth, especially in developed countries. For example, it has been stated that the US Food and Drug Administration (FDA) and other market players are making efforts to alleviate the crisis because of the scarcity of IV saline. In relation to this, Merge, a US-based marketing and development organisation, collaborated with the ground-breaking provider of medical products and services, B. Braun Medical, to launch omnichannel campaign 'Solutions for Life' in May 2020. This programme seeks to ensure an effective supply of IV solutions, approved by the United States FDA.
Report Coverage
Global Veterinary Intravenous (IV) Solutions research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Veterinary Intravenous (IV) Solutions report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Veterinary Intravenous (IV) Solutions competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Veterinary Intravenous (IV) Solutions market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Veterinary Intravenous (IV) Solutions market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Veterinary Intravenous (IV) Solutions market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Merck & Co., Inc.; Dechra Veterinary Products; Sypharma; Animalcare; B. Braun SE; Woods Consulting, LLC; Baxter; Fresenius Kabi
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Veterinary Intravenous (IV) Solutions market based on the below-mentioned segments:
Global Veterinary Intravenous (IV) Solutions Market, By Nutrition Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Global Veterinary Intravenous (IV) Solutions market, By Bag Type
Large Volume Bags (>250 ml)
Small Volume Bags (<250 ml)
Global Veterinary Intravenous (IV) Solutions Market, By End User
Hospital & Clinics
Ambulatory Surgical Centers
Home Care
Global Veterinary Intravenous (IV) Solutions market, Regional Analysis
Key factors driving the market growth include increasing pet ownership, the prevalence of diseases such as anthrax, pancreatitis, and oral disease, and rising awareness about animal welfare. There has been a noticeable increase in the prevalence of various animal diseases and conditions, leading to a higher demand for veterinary IV fluid therapy. Conditions such as disease, dehydration, infections, and surgical procedures often require intravenous fluid administration to support the animal's health and recovery.
New intravenous injection solutions are being introduced by market participants, which is anticipated to accelerate the growth of the global intravenous solutions market in the upcoming years. For example, Baxter International Inc., a global sterile medication production company, announced the FDA approval and commercial launch of premix Bitartrate in 5% Dextrose Injection in September 2021. In adults with severe, acute hypotension, is prescribed to raise blood pressure (low blood pressure). Baxter's formulation is the first and only producer of ready-to-use formulation available in four strengths: 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL).
Parenteral (intravenous) nutrition (PN) product launches by key market players for developing global intravenous solutions are anticipated to propel market growth in the forecast period. For instance, in June 2019, the Indian pharmaceutical market saw the introduction of the intravenous IV products Lifeport and Discport by Eurolife Healthcare, a manufacturer and distributor of specialty infusion & pharmaceuticals. The product, which uses advanced technology to lower the risk of infection, is regarded as a smart intravenous infusion. The fluid treatment is one of the most popular therapies in small animal medicine. In veterinary medicine, intravenous fluid treatment is frequently used to treat dehydration, restore intravascular volume, and provide intravenous (IV) drugs. The ability to put IV catheters is a fundamental nursing skill for veterinary technologists and enables IV fluid therapy for hospitalized patients and emergency presentations. Access to the vascular area also enables other treatments, such as parenteral nutrition, transfusions, and medicines.
The need for nutrition-rich food and a focus on food safety has become increasingly important in the veterinary IV solutions market. Nutrition plays a vital role in supporting the health and recovery of animals, especially those receiving intravenous fluid therapy. IV fluids can be supplemented with essential nutrients, such as vitamins, minerals, and amino acids, to provide complete and balanced nutrition. The demand for nutrition-rich IV fluids has increased as veterinarians recognize the importance of meeting the nutritional needs of animals during illness, surgery, or critical care.
North America, with the bulk of the overall market share, is the dominant market for intravenous solutions. The regional market is being driven by the rapid development of the United States manufacturing capacity owing to a shortage of IV fluids. Moreover, developing countries, including India and China, are increasing their investments in the health sector, which is likely to boost the demand for intravenous solutions. Additionally, manufacturers are implementing new product technologies like offering premixed options for greater convenience and reducing packaging waste.
The development of IV fluids has seen tremendous growth, especially in developed countries. For example, it has been stated that the US Food and Drug Administration (FDA) and other market players are making efforts to alleviate the crisis because of the scarcity of IV saline. In relation to this, Merge, a US-based marketing and development organisation, collaborated with the ground-breaking provider of medical products and services, B. Braun Medical, to launch omnichannel campaign 'Solutions for Life' in May 2020. This programme seeks to ensure an effective supply of IV solutions, approved by the United States FDA.
Report Coverage
Global Veterinary Intravenous (IV) Solutions research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Veterinary Intravenous (IV) Solutions report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Veterinary Intravenous (IV) Solutions competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Veterinary Intravenous (IV) Solutions market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Merck & Co., Inc.; Dechra Veterinary Products; Sypharma; Animalcare; B. Braun SE; Woods Consulting, LLC; Baxter; Fresenius Kabi |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Veterinary Intravenous (IV) Solutions Market from 2021 to 2030.
- Market Forecast for Veterinary Intravenous (IV) Solutions Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Veterinary Intravenous (IV) Solutions competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Veterinary Intravenous (IV) Solutions
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Veterinary Intravenous (IV) Solutions market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Veterinary Intravenous (IV) Solutions market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Merck & Co., Inc.; Dechra Veterinary Products; Sypharma; Animalcare; B. Braun SE; Woods Consulting, LLC; Baxter; Fresenius Kabi
Primary Target Market
- Market Players of Veterinary Intravenous (IV) Solutions
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Veterinary Intravenous (IV) Solutions market based on the below-mentioned segments:
Global Veterinary Intravenous (IV) Solutions Market, By Nutrition Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Global Veterinary Intravenous (IV) Solutions market, By Bag Type
Large Volume Bags (>250 ml)
Small Volume Bags (<250 ml)
Global Veterinary Intravenous (IV) Solutions Market, By End User
Hospital & Clinics
Ambulatory Surgical Centers
Home Care
Global Veterinary Intravenous (IV) Solutions market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive veterinary intravenous iv solutions market market research and competitor analysis for your business to help you develop more profound insights into the veterinary intravenous iv solutions market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the veterinary intravenous iv solutions market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.